Journal
MOLECULAR CELL
Volume 18, Issue 1, Pages 37-48Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2005.02.030
Keywords
-
Categories
Funding
- NINDS NIH HHS [NS038712, NS043578] Funding Source: Medline
Ask authors/readers for more resources
Two central issues in polyglutamine-induced neuro-degeneration are the influence of the normal function of the disease protein and modulation by protein quality control pathways. By using Drosophila, we now directly link host protein function and disease pathogenesis to ubiquitin pathways in the polyglutamine disease spinocerebellar ataxia type 3 (SCA3). Normal human ataxin-3-a polyubiquitin binding protein with ubiquitin protease activity-is a striking suppressor of polyglutamine neurodegeneration in vivo. This suppressor activity requires ubiquitin-associated activities of the protein and is dependent upon proteasome function. Our results highlight the critical importance of host protein function in SCA3 disease and a potential therapeutic role of ataxin-3 activity for polyglutamine disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available